72
Participants
Start Date
May 18, 2018
Primary Completion Date
September 17, 2018
Study Completion Date
September 17, 2018
Levocetirizine IRT 5 mg
Levocetirizine IRT will be available as film-coated tablets. Subjects will receive a single dose of 5 mg levocetirizine IRT. Subjects will receive levocetirizine IRT with 150 mL water in both Part (1 and 2).
Levocetirizine ODT 5 mg
Levocetirizine ODT will be available as oral disintegrating tablet. Subjects will receive a single dose of 5 mg levocetirizine ODT. In Part 1, subjects will receive levocetirizine ODT with 150 mL water and in Part 2 subjects will receive levocetirizine ODT without water.
GSK Investigational Site, Fukuoka
Lead Sponsor
Zensei Pharmaceutical Co., Ltd.
UNKNOWN
GlaxoSmithKline
INDUSTRY